Rusan Pharmaunveils itsstate-of-the-artfacility for APIs in Pithampur, Madhya Pradesh
Rusan Pharma, a leading pharmaceutical company committed to improving healthcare globally and pioneering pain management and addiction solutions worldwide –...
Month: November 2023
Honouring Healthcare Heroes – SitaramJaipuria Foundation celebrates Medical & Healthcare Excellence Awards – 2nd Edition
At the second edition of the SitaramJaipuria Foundation’s prestigious Medical and Healthcare Excellence Awards, Rs. 90 lakhs were awarded to...
Densitas® Selects CancerIQ to Power Lifetime Risk, Patient Adherence as Part of its Industry Leading Mammography Quality AI Platform
Densitas Inc., a global leader in artificial intelligence solutions for breast cancer screening, today announced a partnership with CancerIQ, a precision cancer...
NOSTER Research: Gut bacteria derived metabolites offer alternative treatment for fatty liver disease
In a study recently published in the journal Scientific Reports, researchers from Shizuoka University, Noster Inc, and other groups in Japan identify gut-bacteria derived...
Asep Medical Holdings Inc. is Granted Patent Approval for its AI-based Sepsis Diagnostic Technology in the US
Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that the Company's AI-based sepsis diagnostic technology, called...
Calliditas’ partner Everest Medicines announces China NMPA’s approval of Nefecon® for the treatment of primary IgA nephropathy USA – English 
Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ('Calliditas') today announced that its partner Everest Medicines (HKEX: 1952.HK) ('Everest') announced that China's National Medical Products Administration (NMPA)...
Everest Medicines Announces China NMPA’s Approval of Nefecon® for the Treatment of Primary IgA Nephropathy in Adult Patients USA – English 
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative...
Manhattan Psychology Group Joins ARC Health
ARC Health, a Thurston Group portfolio company, announces the acquisition of Manhattan Psychology Group, PC (MPG), a distinguished behavioral health practice...
PharmAbcine Publishes Study in Science Advances Demonstrating the Potential of PMC-403 in Preclinical Models of Idiopathic Systemic Capillary Leak Syndrome
PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announces the publication of...
Trillium Health Partners to become first in Canada to deploy AI in diagnostic imaging using Sectra Amplifier Services
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) helps Trillium Health Partners (THP) in Canada adopt AI technology with new AI-as-a-service...
